{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:43:17Z","timestamp":1789875797826,"version":"4.0.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T00:00:00Z","timestamp":1326240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028238","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T16:44:12Z","timestamp":1326300252000},"page":"e28238","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":203,"title":["Attitudes and Acceptance of Oral and Parenteral HIV Preexposure Prophylaxis among Potential User Groups: A Multinational Study"],"prefix":"10.1371","volume":"7","author":[{"given":"Andreas B.","family":"Eisingerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Wheelock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela B.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey P.","family":"Garnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Dybul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Piot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,11]]},"reference":[{"key":"ref1","year":"2010"},{"key":"ref2","article-title":"Treating HIV-infected People with Antiretrovirals Protects Partners from Infection.","year":"2011"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women.","volume":"329","author":"Q Abdool Karim","year":"2010","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.","volume":"363","author":"RM Grant","year":"2010","journal-title":"New Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"d4540","DOI":"10.1136\/bmj.d4540","article-title":"Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm.","volume":"343","author":"B Roehr","year":"2011","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"d2613","DOI":"10.1136\/bmj.d2613","article-title":"HIV prevention trial in women is abandoned after drugs show no impact on infection rates.","volume":"342","author":"B Roehr","year":"2011","journal-title":"BMJ"},{"key":"ref7","article-title":"Microbicide Trials Network Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women.","year":"2011"},{"key":"ref8","first-page":"65","article-title":"Interim Guidance: Preexposure Prophylaxis for the Prevention of HIV Infection in Men Who Have Sex with Men.","volume":"60","year":"2011"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(08)60889-2","article-title":"Making HIV prevention programmes work.","volume":"372","author":"SM Bertozzi","year":"2008","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1377\/hlthaff.28.4.962","article-title":"Creating Access To Health Technologies In Poor Countries.","volume":"28","author":"LJ Frost","year":"2009","journal-title":"Health Affair"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/QAD.0b013e328346bd3e","article-title":"Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004).","volume":"25","author":"I McGowan","year":"2011","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/sti.2009.038372","article-title":"A randomised placebo-controlled safety and acceptability trial of PRO 2000 vaginal microbicide gel in sexually active women in Uganda.","volume":"86","author":"A Kamali","year":"2010","journal-title":"Sex Transm Infect"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/152460901300039502","article-title":"Acceptability Research on Female-Controlled Barrier Methods to Prevent Heterosexual Transmission of HIV: Where Have We Been? Where Are We Going?","volume":"10","author":"C Elias","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"ref14","first-page":"242","article-title":"Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men.","volume":"47","author":"AY Liu","year":"2009","journal-title":"J Acq Immun Def Synd"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/09540120701449096","article-title":"Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback.","volume":"20","author":"N Nodin","year":"2008","journal-title":"AIDS Care"},{"key":"ref16","first-page":"378","article-title":"Knowledge and Use of Preexposure and Postexposure Prophylaxis Among Attendees of Minority Gay Pride Events, 2005 Through 2006.","volume":"46","author":"AC Voetsch","year":"2007","journal-title":"JAIDS"},{"key":"ref17","first-page":"376","article-title":"Knowledge and Use of HIV Pre-Exposure Prophylaxis Among Attendees of Minority Gay Pride Events, 2004.","volume":"43","author":"SE Kellerman","year":"2006","journal-title":"JAIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/jwh.2009.1576","article-title":"Acceptability of PrEP for HIV Prevention Among Women at High Risk for HIV.","volume":"19","author":"G Guest","year":"2010","journal-title":"J Womens Health"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1258\/ijsa.2009.009255","article-title":"Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.","volume":"22","author":"JT Galea","year":"2011","journal-title":"Int J STD AIDS"},{"key":"ref20","article-title":"Report on the global AIDS epidemic.","year":"2008"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0092070399272010","article-title":"Sampling in the Twenty-First Century.","volume":"27","author":"S Sudman","year":"1999","journal-title":"J Acad Market Sci"},{"key":"ref22","article-title":"Business Research Methods","author":"DR Cooper","year":"2001"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1207\/S15324796ABM2602_03","article-title":"Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports.","volume":"26","author":"K Schroder","year":"2003","journal-title":"Ann Behav Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2307\/2111580","article-title":"Comparisons of Party Identification and Policy Preferences: The Impact of Survey Question Format.","volume":"37","author":"JA Krosnick","year":"1993","journal-title":"Am J Polit Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acp.2350050305","article-title":"Response strategies for coping with the cognitive demands of attitude measures in surveys.","volume":"5","author":"JA Krosnick","year":"1991","journal-title":"Appl Cognitive Psych"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(07)61053-8","article-title":"Pre-exposure prophylaxis for HIV infection: what if it works?","volume":"370","author":"L Paxton","year":"2007","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11904-011-0078-4","article-title":"Preexposure Prophylaxis for HIV Prevention.","volume":"8","author":"T Kelesidis","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0895-4356(97)00041-3","article-title":"Adherence in AIDS clinical trials: A framework for clinical research and clinical care.","volume":"50","author":"JR Ickovics","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"ref29","first-page":"213","article-title":"Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.","volume":"2","author":"JFP Bridges","year":"2003","journal-title":"Appl Health Econ Health Policy"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.3310\/hta5050","article-title":"Eliciting public preferences for healthcare: a systematic review of techniques.","volume":"5","author":"M Ryan","year":"2001","journal-title":"Health Technol Assess"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/01621459.1996.10476918","article-title":"On the Validity of Using Census Geocode Characteristics to Proxy Individual Socioeconomic Characteristics.","volume":"91","author":"AT Geronimus","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/OLQ.0b013e3181653433","article-title":"Assessment of Self-Reported Sexual Behavior and Condom Use Among Female Sex Workers in India Using a Polling Box Approach: A Preliminary Report.","volume":"35","author":"SE Hanck","year":"2008","journal-title":"Sex Transm Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00007435-200210000-00002","article-title":"Methods to Reduce Social Desirability Bias in Sex Surveys in Low-Development Settings: Experience in Zimbabwe.","volume":"29","author":"S Gregson","year":"2002","journal-title":"Sex Transm Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.socscimed.2009.04.002","article-title":"A comparison of HIV stigma and discrimination in five international sites: The influence of care and treatment resources in high prevalence settings.","volume":"68","author":"S Maman","year":"2009","journal-title":"Soc Sci Med"},{"key":"ref35","first-page":"96","article-title":"Expanding the Space: Inclusion of Most-at-Risk Populations in HIV Prevention, Treatment, and Care Services.","volume":"57","author":"C Beyrer","year":"2011","journal-title":"JAIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002030-200006001-00004","article-title":"Structural barriers and facilitators in HIV prevention: a review of international research.","volume":"14","author":"RG Parker","year":"2000","journal-title":"AIDS"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0968-8080(06)27232-X","article-title":"Health Systems and Access to Antiretroviral Drugs for HIV in Southern Africa: Service Delivery and Human Resources Challenges.","volume":"14","author":"H Schneider","year":"2006","journal-title":"Reprod Health Matter"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/apc.2010.0222","article-title":"Oral Preexposure Anti-HIV Prophylaxis for High-Risk U.S. Populations: Current Considerations in Light of New Findings.","volume":"25","author":"GM Myers","year":"2011","journal-title":"AIDS Patient Care ST"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s11904-010-0062-4","article-title":"Implementation Science of Pre-exposure Prophylaxis: Preparing for Public Use.","volume":"7","author":"K Underhill","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(08)60886-7","article-title":"Behavioural strategies to reduce HIV transmission: how to make them work better.","volume":"372","author":"TJ Coates","year":"2008","journal-title":"Lancet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0140-6736(08)60885-5","article-title":"Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward.","volume":"372","author":"NS Padian","year":"2008","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1371\/journal.pone.0000875","article-title":"Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings.","volume":"2","author":"UL Abbas","year":"2007","journal-title":"PLoS ONE"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/AOG.0b013e31820ce2f0","article-title":"Long-Acting Reversible Contraceptives: Intrauterine Devices and the Contraceptive Implant.","volume":"117","author":"E Espey","year":"2011","journal-title":"Obstet Gynecol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:14:07Z","timestamp":1540322047000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028238"}},"subtitle":[],"editor":[{"given":"Gilda","family":"Tachedjian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028238","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,11]]}}}